Literature DB >> 2187927

Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.

Y Tanaka1, H Tozawa, Y Koyanagi, H Shida.   

Abstract

We established rat T cell lines expressing human T cell leukemia virus type I (HTLV-I) Ag from inbred strains of rats, WKA/H, DA, and F344, to study CTL response against the HTLV-I-infected cells. HTLV-I-specific Ag expressed in these rat cells were HTLV-I gag Ag, p19, p24, and p15, and pX Ag, p40tax and p27rex, but not env Ag, as determined by immunofluorescence and immunoblot assays. By immunization of rats with syngeneic HTLV-I-infected cells, CTL against syngeneic HTLV-I-infected cells and antibodies to HTLV-I Ag were generated in WKA/H and DA rats. The bulk CTL cultures from WKA/H and DA rats lysed specifically syngeneic SV40-transformed kidney cells infected with recombinant vaccinia viruses (RVV) expressing HTLV-I gag and pX Ag, but not those infected with RVV expressing HTLV-I env Ag or a control vaccinia virus. From WKA/H rat CTL cultures, four CTL clones reactive with syngeneic HTLV-I-infected cells were isolated, three of which were specific for p27rex/p21x, but the Ag recognized by the other CTL clone was not defined with any RVV used. These results indicate that HTLV-I gag and pX gene products are recognized by MHC-restricted rat CTL specific for syngeneic HTLV-I-infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187927

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade.

Authors:  S Hanabuchi; T Ohashi; Y Koya; H Kato; F Takemura; K Hirokawa; T Yoshiki; H Yagita; K Okumura; M Kannagi
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.

Authors:  R Tanaka; A Yoshida; T Murakami; E Baba; J Lichtenfeld; T Omori; T Kimura; N Tsurutani; N Fujii; Z X Wang; S C Peiper; N Yamamoto; Y Tanaka
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.

Authors:  T Ohashi; S Hanabuchi; H Kato; Y Koya; F Takemura; K Hirokawa; T Yoshiki; Y Tanaka; M Fujii; M Kannagi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).

Authors:  M Kazanji; J Tartaglia; G Franchini; B de Thoisy; A Talarmin; H Contamin; A Gessain; G de Thé
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.

Authors:  T Ohashi; S Hanabuchi; H Kato; H Tateno; F Takemura; T Tsukahara; Y Koya; A Hasegawa; T Masuda; M Kannagi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.

Authors:  Yuetsu Tanaka; Mariko Mizuguchi; Yoshiaki Takahashi; Hideki Fujii; Reiko Tanaka; Takuya Fukushima; Takeaki Tomoyose; Aftab A Ansari; Masataka Nakamura
Journal:  Retrovirology       Date:  2015-07-01       Impact factor: 4.602

8.  In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukemia in a rat model.

Authors:  K Murata; M Fujita; Y Yamada; Y Higami; I Shimokawa; K Tsukasaki; Y Tanaka; M Maeda; K Furukawa; T Yoshiki; H Shiku; M Tomonaga
Journal:  Jpn J Cancer Res       Date:  1997-05

9.  Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell Leukemia.

Authors:  Megumi Kato; Naoki Imaizumi; Reiko Tanaka; Mariko Mizuguchi; Masaki Hayashi; Takashi Miyagi; Junnosuke Uchihara; Kazuiku Ohshiro; Junpei Todoroki; Kennosuke Karube; Hiroaki Masuzaki; Yuetsu Tanaka; Takuya Fukushima
Journal:  Viruses       Date:  2022-04-03       Impact factor: 5.048

10.  The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Jakob Michaëlsson; Hugo Marcelo R Barbosa; Kimberley A Jordan; Joan M Chapman; Milena K C Brunialti; Walter Kleine Neto; Youko Nukui; Ester C Sabino; Marco Antonio Chieia; Acary Souza Bulle Oliveira; Douglas F Nixon; Esper G Kallas
Journal:  BMC Immunol       Date:  2008-07-29       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.